Item 16. Form 10-K Summary

None.

Apple Inc. | 2020 Form 10-K | 66

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: October 29, 2020	Apple Inc.

	By:	/s/ Luca Maestri
		Luca Maestri
		Senior Vice President, Chief Financial Officer

Power of Attorney

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Timothy D. Cook and Luca Maestri, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:


Name	Title	Date

/s/ Timothy D. Cook	Chief Executive Officer and Director (Principal Executive Officer)	October 29, 2020
TIMOTHY D. COOK

/s/ Luca Maestri	Senior Vice President, Chief Financial Officer (Principal Financial Officer)	October 29, 2020
LUCA MAESTRI

/s/ Chris Kondo	Senior Director of Corporate Accounting (Principal Accounting Officer)	October 29, 2020
CHRIS KONDO

/s/ James A. Bell	Director	October 29, 2020
JAMES A. BELL

/s/ Al Gore	Director	October 29, 2020
AL GORE

/s/ Andrea Jung	Director	October 29, 2020
ANDREA JUNG

/s/ Arthur D. Levinson	Director	October 29, 2020
ARTHUR D. LEVINSON

/s/ Ronald D. Sugar	Director	October 29, 2020
RONALD D. SUGAR

/s/ Susan L. Wagner	Director	October 29, 2020
SUSAN L. WAGNER

Apple Inc. | 2020 Form 10-K | 67

Previous: Item 15. Exhibit and Financial Statement Schedules